USA: Endocanna Health Receives Patent for DNA Tests Aimed at Increased Safety for Cannabis Users
Recent News EndocannaHealthan industry leader in genomic endocannabinoid system testing, has received a first-of-a-kind US patent for its DNA test, which allows hyper-personalized cannabinoid therapies based on the user’s genetics. The patent, Graphical user interfaces for determining custom endocannabinoid genotypes and associated recommendationsdescribes new methods for personalized endocannabinoid medicine. Related content: The Role of Genes: …